FAS and cancer: Fas resistant triple negative MDA-MB-231R cancer cells were treated with a) 50 μM MsDef1 for 60 minutes, b) 5 mM N-acetyl cysteine (NAC) as a negative control and c) NAC treated cells plus 50 μM MsDef1.